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Clear cell hepatocellular carcinoma (HCC) is an uncommon variant of HCC. It is considered to have a
better prognosis than non-clear cell HCC, but recent large studies show that there is some controversy.
DNA image cytometry reveals diploid and non-diploid DNA content tumors that have different
pleomorphisms and mitosis corresponding to different prognoses. Clear cell HCC is classified as focal
or diffuse. Herein, we report a rare case of a 61-year-old male with two adjacent hyper- and hypoechoic
hepatic nodules and an α-fetoprotein concentration of 6,370 ng/mL. Pathologic examination of a specimen
obtained during wedge hepatectomy showed both clear cell and non-clear cell HCC. Bone metastasis was
later found. We suggest that a patient with clear cell HCC should be followed up closely after complete
resection.
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Of 10 major malignancies in Taiwan, hepatocellular
carcinoma (HCC) is the leading cause of death [1]. Better
prognosis is related to histologic features such as encap-
sulation of the tumor [2], eosinophilic HCC with lamellar
fibrosis, and the presence of clear cells [3]. However, there
is controversy about the prognosis of clear cell HCC in
recent large studies comparing it to non-clear cell HCC [4].
Clear cell HCC was previously regarded as an un-
common variant of HCC, but the incidence is high, up to
37.5% and 45% of cases in reports from Hong Kong and
Japan, respectively [4,5]. It has been classified as focal
pattern (clear cells less than one-third of the lesion) or
diffuse pattern (more than one-half of the lesion), with a
significantly better survival rate in the report from Hong
Kong [4]. Clear cell HCC was reported in 9.5% (42/440) of
HCC cases in Taiwan, with no significant difference in
survival rate compared with non-clear cell HCC [6]. Here,
we report a rare case of HCC with two adjacent clear cell and
non-clear cell nodules.
CASE PRESENTATION
A 61-year-old male was referred to our hospital in December
2000 for evaluation of a hepatic tumor. Despite symptoms of
fatigue and loss of appetite, the patient was robust. He was
a chronic hepatitis B carrier. Two nodules were found over
the right lobe of the liver during a routine check-up. On
physical examination, the liver was palpable 1 cm below the
right costal margin with a hard consistency. Significant
laboratory findings included serum glutamic oxaloacetic
transaminase (52 IU/L; normal, < 28 IU/L), lactic dehydro-
genase (337 IU/L; normal, < 255 IU/L), and α-fetoprotein
(6,370 ng/mL; normal, < 10 ng/mL). Abdominal ultraso-
nography revealed a hyperechoic nodule, 2.5 cm in dia-
meter, over the superior aspect of the right lobe of the liver
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(segment 8) and adjacent to its left side, and a hypoechoic
ovoid nodule, 2.0 cm in diameter, with separate capsules
(Figure 1). The same nodules were detected by computeriz-
ed tomography (CT) of the abdomen. Celiac angiography
suggested two hypervascular malignant tumors. The
more hypervascular tumor corresponded to the left side
hypoechoic nodule found on sonography (Figure 2).
Exploratory laparotomy revealed a yellowish nodule,
2.5 cm in diameter, over segment 8 of the right lobe, cor-
responding to the hyperechoic ovoid nodule on ultraso-
nography. Adjacent to this, there was a red solid nodule,
2.0 cm in diameter, corresponding to the hypoechoic tumor
on sonography. At hepatic segmentectomy in segment 8,
both nodules were resected completely with intact capsules.
Pathologic examination showed that the hyperechoic
nodule was clear cell HCC (Figure 3) and that the hypo-
echoic nodule was non-clear cell HCC (Figure 4).
The postoperative course was smooth and α-fetoprotein
dropped to 128 ng/mL after 1 week. However, 4 months
post surgery, a metastatic tumor was detected over the left
shoulder on bone scan. The patient died of acute fulminant
hepatic failure after local irradiation.
DISCUSSION
The histologic subtypes of HCC can be classified as mi-
crotrabecular or macrotrabecular, giant cell carcinoma,
pseudoglandular acinar, solid-anaplastic, fibrolamellar-
oncocytic, clear cell, combined cholangiocellar, or carci-
noid. Each subtype has a different prognosis [7]. The case
presented here had hepatoma with two different cell type
nodules, clear cell (with clear, foamy or vacuolated cyto-
plasm) and non-clear cells, which is very rare. It is generally
accepted that clear cell HCC is mostly due to prominent
accumulation of lipid droplets [8] and sometimes glyco-
gen [7]. Electron microscopy study of 10 clear cell HCC
disclosed both lipid and glycogen accumulation in the
cytoplasm, and cytoplasmic organelles were significantly
fewer than in non-clear cell HCC [9]. However, the complete
pathogenesis of clear cell HCC is not known.
Clear cell HCC has been regarded as an uncommon
variant of HCC, and accounts for 5% to 8.7% of cases in
western countries [8]. In Taiwan, where HCC is highly
prevalent, an incidence of 13.2% (105/795 cases) has been
reported by Professor Hsu Hey-Chi of the National Taiwan
University Hospital (unpublished). Almost the same in-
cidence, 13.3%, has been reported from China [10].
Yang et al reported from Japan that 9.3% (20/215) of
HCC cases were diffuse clear cell HCC and 35.8% (77/215)
contained focal clear cells that were moderately differen-
tiated in 80% of cases. The male to female ratio was 2.3:1
[5]. Lai et al reported from Hong Kong that 12.5% (10/80)
Figure 2. Right hepatic angiography of clear cell hepatocellular carci-
noma (HCC) and non-clear cell HCC. The large, mildly hypervascular
tumor (large V) corresponds to clear cell HCC and the small strongly
hypervascular mass (small V) corresponds to non-clear cell HCC.
Figure 1. Ultrasonography of clear cell hepatocellular carcinoma (HCC)
and non-clear cell HCC. The large hyperechoic nodule mass (large
arrowheads) corresponds to clear cell HCC and the small hypoechoic
mass (small arrow) corresponds to non-clear cell HCC.
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of HCC cases were diffuse clear cell and 25% (20/80)
contained focal clear cells, with a male to female ratio of
1.6:1 [4].
The paraneoplastic manifestations of HCC have been
reported as hypercholesterolemia and hypoglycemia (in
around 30% of cases); erythrocytosis is rare. In clear cell
HCC, hypoglycemia and hypercholesterolemia have rarely
been reported [7].
The diagnosis of both clear cell and non-clear cell HCC
depends on imaging study and fine-needle aspiration cy-
tomorphology. On ultrasonography, a low echoic pattern is
common among smaller HCCs, and a low echoic periphe-
ry pattern tends to prevail with increasing size. The patholo-
gic factors of fatty change and clear cell formation are res-
ponsible for elevating the echogenicity [11]. Our case sup-
ports this theory.
Clear cell HCC is moderately differentiated in 80% of
cases, with abundant glycogen storage and a variable degree
of fat [5]. About 90% of clear cell HCC cases are associated
with liver cirrhosis, more than the 59.3% of non-clear cell
HCC cases. Ultrastructurally, clear cells showed a marked
reduction in the number and size of organelles in the eight
cases examined by Wu et al [9]. Clear cell HCC can be
confused with metastatic hepatic lesions of renal, ovarian,
or adrenal origin. Singh et al reported that fine-needle
aspiration cytomorphology offered a good preoperative
diagnosis of clear cell HCC in four cases with anisonu-
cleosis, nuclear hyperchromasia, macronucleoli, and abun-
dant fine vacuolate in clear cytoplasm [12]. Hepatocyte im-
munostain is the best method to distinguish clear cell HCC
from metastatic lesions, with a sensitivity of 90% and spe-
cificity of 100% [13].
In this case, clear cell HCC had greater echoic change on
sonography than non-clear cell HCC. This supports the idea
that a tumor with fatty changes or clear cell formation has
increased echogenicity and sometimes appears like a
hemangioma [14]. Fatty changes in HCC may be found
using precontrast CT with a low-attenuation area (< –10 H),
but it is sometimes difficult to differentiate based on density
difference. High signal intensity on T1-weighted magnetic
resonance images have been reported in well-differentiated
HCC with fatty changes and/or clear cell formation, but
controversy exists in decreasing signal intensity on T1-
weighted magnetic resonance images. The hypervascularity
and increasing tumor stain on angiography usually corre-
sponds to tumor vascularity in HCC. However, small tumors
that are diffusely infiltrated by fat should be distinguished
from benign conditions such as focal fatty change, lipoma,
or angiomyolipoma [15].
It has been claimed that clear cell HCC has a better
prognosis than non-clear cell HCC [2,4], but there is con-
troversy in recent large serial reports [5,9]. A significantly
better prognosis was reported by Lai et al in Hong Kong [4]:
patients with diffuse clear cell, focal clear cell, and non-clear
cell tumors had 50% survival rates of 14, 6, and 3 weeks,
respectively. The differences between each pair were signi-
ficant (p < 0.001). Clear cell HCC is more sensitive to
transcatheter arterial embolization treatment than other
subtypes of HCC [10]. However, in one study with 215
patients, the survival rates for clear cell HCC at 3 and 5 years
Figure 3. Pathology of clear cell hepatocellular carcinoma (HCC) shows
moderately differentiated neoplastic cells forming thickened trabeculae.
The tumor cells have apparently empty, clear cytoplasm and hyper-
chromatic central or peripheral nuclei with pleomorphism (hematoxylin
& eosin, × 350).
Figure 4. Pathology of non-clear cell hepatocellular carcinoma (HCC)
(common pattern) shows moderately differentiated neoplastic cells
arranged in a trabecular or tubular pattern. The tumor cells have
prominent nuclei, nucleoli, and basophilic cytoplasm (hematoxylin &
eosin, × 350).
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were 54.5% and 33.3%, not significantly different from
those for non-clear cell HCC (74.3% and 46.1%, respectively)
[5]. A similar result was reported from 118 cirrhotic cases in
France [16].
What is important in interpreting prognosis? DNA
imaging cytometry shows that clear cell HCC is comprised
of two groups, one with bland morphologic features and
diploid DNA content and the other with aggressive
morphologic features and aneuploid DNA content. This
may explain the discrepant literature reports regarding the
prognosis of this tumor [17].
In this case, clear cell and non-clear cell HCC were found
in two adjacent nodules with moderately differentiated
neoplasm cells and intact capsules. They were resected
completely. However, tumor metastasis was found very
soon, leading to a poor prognosis. We suggest that clear cell
HCC should be followed up as regularly as non-clear cell
HCC.
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